Browse our extensive catalog of high-quality chemicals for research and development.
| Product Name | Description | CAS Number | Molecular Formula | Molecular Weight | Description |
|---|---|---|---|---|---|
| 4-Defluoro-2-fluoro Haloperidol-d4 | 4-[4-(4-Chlorophenyl-d4)-4-hydroxy-1-piperidinyl]-1-(2-fluorophenyl)-1-butanone; | 1795021-11-2 | C21H19D4ClFNO2 | 379.89 | 4-[4-(4-Chlorophenyl-d4)-4-hydroxy-1-piperidinyl]-1-(2-fluorophenyl)-1-butanone;
|
| 6-Defluoro-(ethoxycarbonyl)piperazinyl-7-N-ethoxycarbonyl Norfloxacin | 6,7-bis(4-(ethoxycarbonyl)piperazin-1-yl)-1-ethyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; Nofloxacin Impurity J | NA | C26H35N5O7 | 529.59 | 6,7-bis(4-(ethoxycarbonyl)piperazin-1-yl)-1-ethyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; Nofloxacin Impurity J
|
| 4-Defluoro-2-fluoro Haloperidol Decanoate | 1798004-21-3 | C31H42FNO3 | 495.67 | ||
| 4-Defluoro-2-fluoro Haloperidol Decanoate-d19 | NA | C31H23D19FNO3 | 514.79 | ||
| 3-Des-(4-fluorophenyl) 3-(4-Fluorobiphen-3-yl) Aprepitant | NA | C29H25F7N4O3 | 610.52 | ||
| (+)-Lycopsamine | (2S,3S)-2,3-Dihydroxy-2-(1-methylethyl)butanoic Acid [(1R,7aR)-2,3,5,7a-Tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl]methyl Ester; [1R-[1alpha,7(2S*,3S*),7abeta]]-2,3-dihydroxy-2-(1-methylethyl)butanoic Acid (2,3,5,7a-Tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl)methyl Ester; Lycopsamine; Retronecine 9-((-)-viridiflorate) (2S,3S)-2,3-Dihydroxy-2-(1-methylethyl)butanoic Acid [(1R,7aR)-2,3,5,7a-Tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl]methyl Ester; [1R-[1alpha,7(2S*,3S*),7abeta]]-2,3-dihydroxy-2-(1-methylethyl)butanoic Acid (2,3,5,7a-Tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl)methyl Ester; Lycopsamine; Retronecine 9-((-)-viridiflorate) | 10285-07-1 | C15H25NO5 | 299.36 | (2S,3S)-2,3-Dihydroxy-2-(1-methylethyl)butanoic Acid [(1R,7aR)-2,3,5,7a-Tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl]methyl Ester; [1R-[1alpha,7(2S*,3S*),... |
| Defluoro Linezolid | N-[[(5S)-3-[4-(4-Morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide; | 556801-15-1 | C16H21N3O4 | 319.36 | N-[[(5S)-3-[4-(4-Morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
|
| (+)-Lycopsamine-D7 | (2S,3S)-2,3-Dihydroxy-2-(1-methylethyl)butanoic Acid [(1R,7aR)-2,3,5,7a-Tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl]methyl Ester-D7; [1R-[1α,7(2S*,3S*),7aβ]]-2,3-dihydroxy-2-(1-methylethyl)butanoic Acid (2,3,5,7a-Tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl)methyl Ester-D7; Lycopsamine-D7; Retronecine 9-((-)-viridiflorate)-D7; | NA | C15H18D7NO5 | 306.41 | (2S,3S)-2,3-Dihydroxy-2-(1-methylethyl)butanoic Acid [(1R,7aR)-2,3,5,7a-Tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl]methyl Ester-D7; [1R-[1α,7(2S*,3S*)... |
| Defluoro Linezolid-d3 | N-[[(5S)-3-[4-(4-Morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide-d3; | 1795786-92-3 | C16H18D3N3O4 | 322.37 | N-[[(5S)-3-[4-(4-Morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide-d3;
|
| 2-Defluro-2-methylene Sofosbuvir | NA | C22H28N3O9P | 509.45 |
Page 1820 of 10017